phosphatidylcholines has been researched along with l 743,872 in 13 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (l 743,872) | Trials (l 743,872) | Recent Studies (post-2010) (l 743,872) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 1,724 | 75 | 849 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sims-McCallum, RP | 1 |
Bartlett, K; Batty, DS; Choo, E; Marra, F; Risovic, V; Sivak, O; Wasan, KM | 1 |
Perfect, JR | 1 |
Edwards, JE; Fu, Y; Ibrahim, AS; Spellberg, B | 1 |
Clemons, KV; Fernandez, B; Imai, J; Singh, G; Stevens, DA | 1 |
Andes, D; Gauthier, GM; Nork, TM; Prince, R | 1 |
Cornila, C; Fohrer, C; Fornecker, L; Herbrecht, R; Marinescu, C; Nivoix, Y | 1 |
Adler-Moore, J; Avanesian, V; Edwards, JE; Fu, Y; Ibrahim, AS; Schwartz, J; Spellberg, B | 1 |
Bartlett, K; Risovic, V; Rosland, M; Sivak, O; Wasan, KM | 1 |
Cheung, C; Feldmesser, M; Gialanella, P; Guo, Y | 1 |
Beltrame, A; Cerana, M; De Maria, A; Di Biagio, A; Pacini, D | 1 |
Cappelli, B; Castagnola, E; Cuzzubbo, D; Faraci, M; Lanino, E; Moresco, L; Moroni, C | 1 |
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA | 1 |
2 review(s) available for phosphatidylcholines and l 743,872
Article | Year |
---|---|
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Antifungal combination treatment: a future perspective.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Echinocandins; Forecasting; Humans; In Vitro Techniques; Lipopeptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
1 trial(s) available for phosphatidylcholines and l 743,872
Article | Year |
---|---|
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole | 2008 |
10 other study(ies) available for phosphatidylcholines and l 743,872
Article | Year |
---|---|
Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Child; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Neutropenia; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2003 |
Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley | 2004 |
Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Caspofungin; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Drug Combinations; Echinocandins; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Mucormycosis; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rhizopus; Survival | 2005 |
Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Caspofungin; Central Nervous System Fungal Infections; Drug Combinations; Drug Therapy, Combination; Echinocandins; Lipopeptides; Male; Mice; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols | 2005 |
Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Combinations; Echinocandins; Endophthalmitis; Humans; Lipopeptides; Male; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure | 2005 |
Comparison of antifungal treatments for murine fusariosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Drug Combinations; Echinocandins; Fusarium; Kidney; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Mycoses; Neutropenia; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Echinocandins; Galactose; Injections, Intravenous; Lipopeptides; Male; Mannans; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2007 |
Development of candidemia on caspofungin therapy: a case report.
Topics: Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Catheters, Indwelling; Cross Infection; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Fungemia; Humans; Lipopeptides; Male; Pancreaticoduodenectomy; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications | 2006 |
Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Combinations; Echinocandins; Female; Fluconazole; Fungemia; Humans; Ileostomy; Lipopeptides; Middle Aged; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Practice Guidelines as Topic | 2007 |
Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
Topics: Administration, Inhalation; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Lung Diseases, Fungal; Mitochondrial Diseases; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Syndrome; Transplantation, Homologous | 2007 |